Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection

mBio(2021)10.1128/mbio.00635-21Source: DataRank Database

Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection is a research paper published in mBio (2021). On theSindex it has a DataRank of 0. It has been cited 65 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access65 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 4.66)OA: goldTopics (46)Linked Datasets (14)DataCite Reuse (14)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Lara Dsouza ORCID,Zhilong Yang ORCID,Anil Pant

Live enrichment

PubMed:34517756 PMC:PMC8546648 OpenAlex:https://openalex.org/W3200105886

HHS | National Institutes of Health

Grant: R01 AI143709

FWCI

4.66

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/mbio.00635-21

publisherhttps://doi.org/10.1128/mbio.00635-21

publisherhttps://journals.asm.org/doi/pdf/10.1128/mBio.00635-21

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34517756

repositoryhttp://europepmc.org/pmc/articles/PMC8546648

Fields of Study

Endoplasmic Reticulum Stress and Diseaseinterferon and immune responsesVirus-based gene therapy researchAnimalsHost Microbial InteractionsHost-Pathogen InteractionsHumansMetabolic Networks and PathwaysMiceSignal TransductionVirus DiseasesVirus ReplicationViruses

MeSH Terms

Host Microbial InteractionsAnimalsHumansVirus DiseasesVirus ReplicationVirusesSignal TransductionMiceMetabolic Networks and PathwaysHost-Pathogen Interactions

Keywords

BiologyViral replicationReprogrammingCellular metabolismObligateCell metabolismSignal transductionMetabolic pathwayCell biologyVirusCell signalingCellMetabolismVirologyGeneticsGeneHIF-1αMetabolic DisordersHost-virus InteractionsHif-1alphaAmpk PathwayPi3k-akt-mtorGrowth Signaling

Sustainable Development Goals

SDG 0: Zero hunger

Additional file 1 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620363.v1figshare

Additional file 1 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620363figshare

Additional file 5 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620375.v1figshare

Additional file 5 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620375figshare

Additional file 6 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620378.v1figshare

Additional file 6 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620378figshare

Additional file 3 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620369figshare

Additional file 3 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620369.v1figshare

Additional file 2 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620366figshare

Additional file 4 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620372figshare

Additional file 7 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620381.v1figshare

Additional file 4 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620372.v1figshare

Additional file 2 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620366.v1figshare

Additional file 7 of Fuzzy optimization for identifying antiviral targets for treating SARS-CoV-2 infection in the heart

10.6084/m9.figshare.26620381figshare